日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

SETDB2 Mitigates Podocyte Dysfunction in Diabetic Kidney Disease Through Epigenetic Silencing of SMAD3

SETDB2通过表观遗传沉默SMAD3减轻糖尿病肾病中的足细胞功能障碍

Li, Lanfang; Jiang, Shimin; Jin, Qi; Qu, Peng; Guo, Yingjie; Lan, Xushan; Li, Xinyu; Sun, Cuiting; Ai, Sinan; Li, Xin; Sun, Weiliang; Guo, Jing; Li, Wenge; Peng, Liang; Liu, Lihong

Remodeling the Inflammatory Microenvironment: Nanomaterial-Based Targeted Strategies for Systemic Lupus Erythematosus and Lupus Nephritis

重塑炎症微环境:基于纳米材料的系统性红斑狼疮和狼疮性肾炎靶向治疗策略

Zhou, Cheng; Li, Jiayi; Zhang, Jian; Wang, Haifeng; Lu, Haitao; Shang, Shunlai; Li, Wenge

Evolving epidemiology and improving safety of rechallenge in immune checkpoint inhibitor-associated acute kidney injury: an updated meta-analysis

免疫检查点抑制剂相关急性肾损伤的流行病学演变及再次用药安全性提高:一项更新的荟萃分析

Zhang, Danyang; Gu, Xia; Li, Danyang; Yang, Yue; Li, Wenge

Effect of tolvaptan on the prognosis of patients with rapidly progressive autosomal dominant polycystic kidney disease: a prospective open-label study

托伐普坦对快速进展型常染色体显性多囊肾病患者预后的影响:一项前瞻性开放标签研究

Zhou, Li; Li, Wenge

Research progress on the intrinsic link between the occurrence and progression of malignant tumors, chronic kidney disease and drug safety

恶性肿瘤发生发展、慢性肾脏病与药物安全性之间内在联系的研究进展

Zhang, Danyang; Jiang, Shimin; Liu, Lin; Lu, Jian; Li, Wenge

Geographical differences in the prevalence of diabetic kidney disease in middle-aged and elderly patients in China: an analysis based on the Bayesian conditional autoregressive model

中国中老年糖尿病肾病患病率的地域差异:基于贝叶斯条件自回归模型的分析

Shang, Xinru; Sun, Shuaigang; Jiang, Shimin; Deng, Zekai; Wang, Shunwei; Lu, Jian; Li, Wenge

Advancing the clinical assessment of glomerular podocyte pathology in kidney biopsies via super-resolution microscopy and angiopoietin-like 4 staining.

通过超分辨率显微镜和血管生成素样 4 染色推进肾活检中肾小球足细胞病理的临床评估

Liu Xiaojing, Wang Suxia, Liu Gang, Wang Yan, Shang Shunlai, Zou Guming, Jiang Shimin, Wang Xuliang, Yang Li, Li Wenge

Advances in precision medicine for lupus nephritis: biomarker- and AI-driven diagnosis and treatment response prediction and targeted therapies

狼疮性肾炎精准医学进展:基于生物标志物和人工智能的诊断和治疗反应预测以及靶向治疗

Shang, Shunlai; Xia, Jikai; He, Guosen; Zheng, Yan; Zhang, Jian; Lu, Haitao; Wang, Haifeng; Li, Wenge; Li, Qinggang; Chen, Xiangmei

Immunosenescence, Physical Exercise, and their Implications in Tumor Immunity and Immunotherapy

免疫衰老、体育锻炼及其在肿瘤免疫和免疫治疗中的作用

Yu, Xin; Pei, Wei; Li, Bei; Sun, Shengrong; Li, Wenge; Wu, Qi

Mizoribine or Cyclophosphamide for Lupus Nephritis: A Randomized Clinical Trial

米佐立宾或环磷酰胺治疗狼疮性肾炎:一项随机临床试验

Dong, Zheyi; Luo, Ping; Sun, Shiren; Ni, Zhaohui; He, Yani; Huang, Xiangyang; Liu, Zhangsuo; Wu, Zhenbiao; Zhang, Xinzhou; Liao, Yunhua; Zhao, Jianhong; Lin, Hongli; Zhang, Xiao; Fu, Rongguo; Ding, Guohua; Xu, Yan; Wang, Lihua; Xiao, Yuefei; Shi, Shumei; Zuo, Xiaoxia; Li, Zhanguo; Qiao, Li; Wang, Rong; Li, Wenge; Wan, Jianxin; Li, Ying; Guan, Tianjun; Deng, Xiaoli; Wu, Xiaoyan; Zheng, Hongguang; Chen, Jianghua; He, Lan; Yamaguchi, Seika; Wang, Hua; Cai, Guang-Yan; Zhang, Li; Chen, Xiangmei